Tcg-Crossover-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "CNTA",
  "NKTR",
  "ABVX",
  "ATXS",
  "TNGX",
  "GPCR",
  "SLN",
  "SVRA",
  "THRD",
  "TRML",
  "TYRA",
  "MLYS",
  "KROS",
  "ADVM",
  "AVTX",
  "AMLX",
  "FULC",
  "UPB",
  "RAPT",
  "MBX",
  null,
  "SLNO",
  "COGT",
  "DYN",
  "CMPS",
  "CDTX",
  "EYPT",
  "KURA",
  "KOD",
  "VTYX",
  "VTGN",
  "TRDA",
  "XNCR",
  "CABA",
  "CGON",
  "DNTH",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 38
Total Value: 733085569
Accession Number: 0001214659-25-007553
Form Type: 13F-HR
CIK: tcg-crossover-management
Manager Name: Tcg-Crossover-Management

Data Enrichment

97% identified

37 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

38 positions • $733.1M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

Fulcrum Therapeutics, Inc.

FULC|359616109

Shares:5.3M

Value:$15.1M

% of Portfolio:2.1% ($15.1M/$733.1M)

Astria Therapeutics, Inc.

ATXS|04635X102

Shares:2.8M

Value:$14.7M

% of Portfolio:2.0% ($14.7M/$733.1M)

Tango Therapeutics, Inc.

TNGX|87583X109

Shares:10.7M

Value:$14.7M

% of Portfolio:2.0% ($14.7M/$733.1M)

COMPASS Pathways plc

CMPS|20451W101

Shares:3.9M

Value:$11.0M

% of Portfolio:1.5% ($11.0M/$733.1M)

Kura Oncology, Inc.

KURA|50127T109

Shares:1.4M

Value:$9.4M

% of Portfolio:1.3% ($9.4M/$733.1M)

Third Harmonic Bio, Inc.

THRD|88427A107

Shares:2.5M

Value:$8.7M

% of Portfolio:1.2% ($8.7M/$733.1M)

Silence Therapeutics plc

SLN|82686Q101

Shares:3.0M

Value:$8.6M

% of Portfolio:1.2% ($8.6M/$733.1M)

Adverum Biotechnologies, Inc.

ADVM|00773U207

Shares:1.8M

Value:$7.9M

% of Portfolio:1.1% ($7.9M/$733.1M)

Vistagen Therapeutics, Inc.

VTGN|92840H400

Shares:2.7M

Value:$6.7M

% of Portfolio:0.9% ($6.7M/$733.1M)

008064107

Shares:2.2M

Value:$5.6M

% of Portfolio:0.8% ($5.6M/$733.1M)

Entrada Therapeutics, Inc.

TRDA|29384C108

Shares:585.0K

Value:$5.3M

% of Portfolio:0.7% ($5.3M/$733.1M)

MBX Biosciences, Inc.

MBX|55287L101

Shares:650.0K

Value:$4.8M

% of Portfolio:0.7% ($4.8M/$733.1M)

Avalo Therapeutics, Inc.

AVTX|05338F306

Shares:483.0K

Value:$3.9M

% of Portfolio:0.5% ($3.9M/$733.1M)

Kodiak Sciences Inc.

KOD|50015M109

Shares:1.1M

Value:$3.2M

% of Portfolio:0.4% ($3.2M/$733.1M)

NEKTAR THERAPEUTICS

NKTR|640268108

Shares:4.0M

Value:$2.7M

% of Portfolio:0.4% ($2.7M/$733.1M)

Ventyx Biosciences, Inc.

VTYX|92332V107

Shares:316.2K

Value:$363.6K

% of Portfolio:0.0% ($363.6K/$733.1M)

Cabaletta Bio, Inc.

CABA|12674W109

Shares:86.8K

Value:$120.2K

% of Portfolio:0.0% ($120.2K/$733.1M)

Keros Therapeutics, Inc.

KROS|492327101

Shares:0

Value:$0

% of Portfolio:0.0% ($0/$733.1M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Fulcrum Therapeutics, Inc.(FULCcusip359616109)	5.3M	QoQ 0.00% (-0) YoY NEW(+5.3M)	All Managers (Combined)	$15.1M	2.1% ($15.1M/$733.1M)	QoQ -38.72% (-$9.6M) YoY NEW(+$15.1M)
Astria Therapeutics, Inc.(ATXScusip04635X102)	2.8M	QoQ 0.00% (-0) YoY -47.68% (-2.5M)	All Managers (Combined)	$14.7M	2.0% ($14.7M/$733.1M)	QoQ -40.26% (-$9.9M) YoY -80.15% (-$59.6M)
Tango Therapeutics, Inc.(TNGXcusip87583X109)	10.7M	QoQ 0.00% (-0) YoY NEW(+10.7M)	All Managers (Combined)	$14.7M	2.0% ($14.7M/$733.1M)	QoQ -55.66% (-$18.5M) YoY NEW(+$14.7M)
COMPASS Pathways plc(CMPScusip20451W101)	3.9M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$11.0M	1.5% ($11.0M/$733.1M)	QoQ -24.33% (-$3.5M) YoY -65.62% (-$21.1M)
Kura Oncology, Inc.(KURAcusip50127T109)	1.4M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$9.4M	1.3% ($9.4M/$733.1M)	QoQ -24.22% (-$3.0M) YoY -69.05% (-$21.0M)
Third Harmonic Bio, Inc.(THRDcusip88427A107)	2.5M	QoQ 0.00% (-0) YoY NEW(+2.5M)	All Managers (Combined)	$8.7M	1.2% ($8.7M/$733.1M)	QoQ -66.27% (-$17.1M) YoY NEW(+$8.7M)
Silence Therapeutics plc(SLNcusip82686Q101)	3.0M	QoQ 0.00% (-0) YoY -7.94% (-261.8K)	All Managers (Combined)	$8.6M	1.2% ($8.6M/$733.1M)	QoQ -59.01% (-$12.3M) YoY -87.98% (-$62.6M)
Adverum Biotechnologies, Inc.(ADVMcusip00773U207)	1.8M	QoQ 0.00% (-0) YoY NEW(+1.8M)	All Managers (Combined)	$7.9M	1.1% ($7.9M/$733.1M)	QoQ -6.42% (-$538.9K) YoY NEW(+$7.9M)
Vistagen Therapeutics, Inc.(VTGNcusip92840H400)	2.7M	QoQ 0.00% (-0) YoY NEW(+2.7M)	All Managers (Combined)	$6.7M	0.9% ($6.7M/$733.1M)	QoQ -15.25% (-$1.2M) YoY NEW(+$6.7M)
(cusip008064107)✕	2.2M	QoQ 0.00% (-0) YoY +1.79% (-39.5K)	All Managers (Combined)	$5.6M	0.8% ($5.6M/$733.1M)	QoQ -5.28% (-$313.7K) YoY -91.35% (-$59.5M)
Entrada Therapeutics, Inc.(TRDAcusip29384C108)	585.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$5.3M	0.7% ($5.3M/$733.1M)	QoQ -47.71% (-$4.8M) YoY -36.20% (-$3.0M)
MBX Biosciences, Inc.(MBXcusip55287L101)	650.0K	QoQ 0.00% (-0) YoY NEW(+650.0K)	All Managers (Combined)	$4.8M	0.7% ($4.8M/$733.1M)	QoQ -59.95% (-$7.2M) YoY NEW(+$4.8M)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	483.0K	QoQ 0.00% (+0) YoY NEW(+483.0K)	All Managers (Combined)	$3.9M	0.5% ($3.9M/$733.1M)	QoQ +7.80% (+$280.1K) YoY NEW(+$3.9M)
Kodiak Sciences Inc.(KODcusip50015M109)	1.1M	QoQ 0.00% (-0) YoY +27.28% (-245.5K)	All Managers (Combined)	$3.2M	0.4% ($3.2M/$733.1M)	QoQ -71.80% (-$8.2M) YoY -32.12% (-$1.5M)
NEKTAR THERAPEUTICS(NKTRcusip640268108)	4.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$2.7M	0.4% ($2.7M/$733.1M)	QoQ -26.88% (-$1.0M) YoY -27.21% (-$1.0M)
Ventyx Biosciences, Inc.(VTYXcusip92332V107)	316.2K	QoQ 0.00% (-0) YoY -61.23% (-499.5K)	All Managers (Combined)	$363.6K	0.0% ($363.6K/$733.1M)	QoQ -47.48% (-$328.8K) YoY -91.89% (-$4.1M)
Cabaletta Bio, Inc.(CABAcusip12674W109)	86.8K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$120.2K	0.0% ($120.2K/$733.1M)	QoQ -38.98% (-$76.8K) YoY -91.88% (-$1.4M)
Keros Therapeutics, Inc.(KROScusip492327101)	0	QoQ EXITED(-550.0K) YoY EXITED(-879.3K)	All Managers (Combined)	$0	0.0% ($0/$733.1M)	QoQ EXITED(-$8.7M) YoY EXITED(-$58.2M)